New Jersey Biotech News (United States)

Niiki Pharma Inc. announced that results from the completed Phase I dose escalation trial of its GRP78 targeted anti-cancer agent, NKP-1339, will be presented at the Annual Meeting of the American Society of Clinical Oncology to be held in Chicago.

Chris Pegut, Flex MBA Student and Vice President of the Student Government Association (SGA), writes how a few months in the Rutgers MBA program helped him get a great job.

ClorDiSys Solutions, Inc announces the launch of an international decontamination team to service the pharmaceutical industry. The team will fumigate facilities and eliminate all microbial organisms as part of their contamination control plans.

Searching for a senior level opportunity requires the ability to expand your network and get in front of the right people at the right time. CareerAdvantge will allow you to identify companies in the hiring mode before the jobs get posted.

Niiki Pharma Inc. announced that results from the completed Phase I dose escalation trial of its GRP78 targeted anti-cancer agent, NKP-1339, will be presented at the Annual Meeting of the American Society of Clinical Oncology to be held in Chicago.

Niiki Pharma announced the presentation of preclinical data at the American Association for Cancer Research Annual Meeting in Chicago, Illinois for its novel compound, NKP-2235, the first highly orally bioavailable gallium-based anti-cancer agent.

Chris Pegut, Flex MBA Student and Vice President of the Student Government Association (SGA), writes how a few months in the Rutgers MBA program helped him get a great job.

C3i Inc has been selected by Human Genome Sciences (HGS) to provide multilingual help desk support for their Veeva CRM deployment in Europe and other applications on iPad2.

SequenceBase Corp. announces the launch of the USGENE® BLAST® Search Portal. All sequences from the USPTO are now available via the web-based USGENE BLAST Search Portal with a limited time offer of completely free-of-charge access for 30 days.

Niiki Pharma announced today the formation of its Scientific Advisory Board. Daniel Haller M.D. will chair the advisory board, and will be joined by Lee Ellis M.D. and Matt Kulke M.D. The Board will provide clinical and strategic guidance.

Niiki Pharma Inc. announced today that it has completed the dose escalation portion of the Phase I clinical trial of its lead product, NKP-1339, a first-in-class small molecule that down-regulates GRP78, a key tumor survival and anti-apoptosis factor

C3i industry experts will deliver 6 presentations, 1 tutorial and 1 demo session at the Oracle Health Sciences User Group Conference (OHSUG) in Toronto, 16 – 19 Oct. 2011.

C3i, the leader in clinical technology support services for the life sciences industry, will discuss practices to maintain and process information derived from imaging data in oncology at the SCDM Conference in Baltimore,MD /11-13 September 2011/.

Skila announces another top pharmaceutical company has standardized on the Skila iLaunch solution adding a fourth product launch. Once other brand teams saw the initial launch team's success, they too wanted to achieve the same Skila solution impact.

C3i, the leader in clinical technology support services for the life sciences industry, will discuss practices to maintain and process information derived from imaging data in oncology during the 47th DIA Annual Meeting 2011 in Chicago, IL.

At BioPlastek 2011 Forum on June 27-29 in New York, Virent to present details on just announced new technology for production of 100% plant-based PET bottle

C3i, a world leader in clinical trial support services, today announced the signing of its newest client, XBiotech, Inc. C3i will provide a full-service technical solution to support Xbiotech's program of promising clinical trials.

ClorDiSys Solutions, Inc announces the launch of an international decontamination team to service the pharmaceutical industry. The team will fumigate facilities and eliminate all microbial organisms as part of their contamination control plans.

Go!Foton adds new FLE 1100 model in UV wavelength

The MACK Group, LLC (MACK) Completes the Interior Demolition, Decontamination and Decommissioning of a 35,000sf Former Biopharmaceutical Manufacturing Facility Located in Northern NJ.

ARTClinica introduces its new eClinical software solution. The solution will be demonstrated at the Partnerships in Partnerships in Clinical Trials Conference taking place on March 30 – April 1 in Phoenix, AZ.

Searching for a senior level opportunity requires the ability to expand your network and get in front of the right people at the right time. CareerAdvantge will allow you to identify companies in the hiring mode before the jobs get posted.

Go!Foton announces a new fluorescence detector to replace the FLE 1000: the FLE 1100.

VENENUM Biodesign launched a new website with improved user interface and navigation to facilitate the location of key information. These changes will immediately make their services more accessible to the research community.

Life Sciences industries continuously look forward to aggressive growth in Asia, particualry China and India. Singapore with it’s strong healthcare system and local bio/med devices workforce is a must for any firm to have it in the portfolio mix.

ASCO survey of Medicare and Private Insurers by Reimbursement Intelligence Reported in Oncology Business Review

Viora announces a partnership with LaserTouch Soho, Manhattan, NY for expansion of aesthetic medical training for the Reaction™.

A synergistic relationship between the two parties is set to revolutionize modern boutique medicine services; and diagnostic testing, and create sturdy benchmarks for healthcare overall.

GenScript’s Peptide Array service provides custom solutions to researchers’ peptide screening applications with two delivery format.

Amber Czajkowski, a thin-films engineer at Edmund Optics, will speak on “Illumination for Surgery and Medical Diagnosis” at the Symposium on Advanced Bio-optics and Related Medical Device Regulatory Considerations in Hong Kong on April 16, 2010.

Skila has four of its experts featured in Volume 10.1 of the Journal of Medical Marketing. “Pricing, Market Access and the Return of Reality” is the title of the latest volume of the prominent peer-reviewed Journal of Medical Marketing.

Skila, a leading provider of knowledge agility and stakeholder collaboration management solutions, today announced a new and expanded Master Services Agreement (MSA) with Nycomed.

Skila, a leading provider of knowledge agility and stakeholder collaboration management solutions, announces that a Top-20 US pharmaceutical company has chosen Skila’s Launch Readiness™ solution for two of its upcoming product launches.

GenScript’s epitope mapping services can be applied to vaccine development for cancer and infectious diseases.

GenScript draws attention from UPENN School of Medicine for obtaining best quality products and services.

There has always been controversy with Jehovah's Witnesses and blood transfusions. This news report helps provide a good reference point for Jehovah's Witnesses and blood transfusions.

GenScript plans to expand its Japanese market from its capital.

GenScript’s click peptide service aims to handle difficult peptide you intended to study.

iKOL offers real-time knowledge® of more than 2.5 million leading thought leaders representing 400+ disease areas in more than 60 leading countries across thousands of hospitals and institutions.

Clordisys Solutions, Inc of Lebanon, NJ announces that testing has proven chlorine dioxide gas as being effective in inactivating beta-lactams in addition to its status as a sterilant with the US EPA.

New York Times and USA Today bestselling author of more than twenty books, Caridad Pineiro, has a new book entitled SINS OF THE FLESH out just in time for Halloween.

Skila, A Sela2 Company, has recently expanded its active client base by closing nine expansions across five current clients in Q4 of its fiscal year, ending September 30, 2009.

Benefiting from its patent-pending OptimumGene™ gene optimization technology breakthrough which can achieve a 10-fold or greater increase in protein expression, GenScript now offers a first-to-market guaranteed Gene-to-Protein service package.

Skila announces the launch of two new state-of-the-art solutions for facilitating launch preparation and clinical trial tracking in the life science industry.

Halocarbon has entered into a licensing agreement with IBM to access IBM’s industry-leading portfolio of patents related to hexafluoroisopropanol-based photoresists for semiconductor manufacturing.

Skila’s iAdvocate Mobile™ solution enhances the iAdvocate™ opinion leader management solution by enabling users to quickly and easily access their iAdvocate™ solution from smart phones.

Skila, A Sela2 Company, announces the addition of mobile capabilities for Skila solutions. Skila’s mobile solutions allow knowledge agility by enabling users to quickly and easily access their Skila solutions from smart phones.

GenScript expands its drug discovery services to assay development.

GenScript celebrates its 5th anniversary for its peptide services by giving customers 20% off for standard peptide synthesis and modifications.

GenScript adds THE™ Anti-DYKDDDDK mAb to the THE™ antibody series.

Fluorotherm, supplier of fluoropolymer products, contributes to the success of many businesses due to the versatility of PTFE, PFA, FEP, and other fluoroplastics.

GenScript upgrades its plasmid production platform to enable wider scope downstream applications.

Seven years ago Thomas was a teen facing death, he needed a heart transplant. Now he’s investing $1000 in the future of organ replacement. Through the Methuselah Foundation MLife Science Fund an individual donor like Thomas can change lives.

Dislocated workers in New Jersey from any employment sector may be eligible to choose to enroll in one of the Rutgers Mini-MBA™ programs (Individual Training Accounts of up to $4,000 each).